Loading organizations...

§ Private Profile · 127 Western Avenue Boston, MA 02134
Develops automated DNA-based platforms for digital data storage and computation, serving enterprise customers with extreme data archival needs.
Catalog is a Boston, Massachusetts-based company that develops automated DNA-based platforms for digital data storage and computation. The enterprise utilizes synthetic DNA and inkjet-like printing technology to facilitate high-density data archiving and parallel processing for industries experiencing massive enterprise data expansion. In 2021, the organization successfully secured $35 million in Series B financing, bringing its total raised capital to at least $45.5 million. This funding round was led by Hanwha Impact Partners, with additional backing from venture capital firms including SOSV and its life sciences accelerator IndieBio. Recognized as a World Economic Forum Technology Pioneer in 2024, the firm previously demonstrated its computational capabilities by encoding and searching eight Shakespearean tragedies within a single synthetic DNA test tube. Catalog was founded in 2016 by Massachusetts Institute of Technology (MIT) scientists Hyunjun Park, Timothy Lu, and Nathaniel Roquet.
Catalog has raised $65.8M across 8 funding rounds.
Catalog has raised $65.8M in total across 8 funding rounds.
Catalog Technologies is a Boston-based startup founded in 2016 that develops DNA-based platforms for digital data storage and computation, leveraging synthetic DNA to overcome limitations of traditional electronic media like high energy use, scalability issues, and security vulnerabilities.[1][3][6] The company builds products such as the Shannon DNA writer, capable of storing up to 1.63TB of compressed data per run at speeds over 10MB/sec, and has achieved milestones like encoding and commercially delivering the first book in DNA.[1][3] It serves sectors needing massive, energy-efficient data handling, including AI workloads, financial fraud detection, manufacturing defect discovery, and energy sector signal processing, with growth evidenced by $50M in total funding (including a $35M Series B in 2021) and partnerships like Seagate.[3][4]
Catalog addresses exploding global data volumes—projected at 175 zettabytes by 2025—by enabling low-energy, parallelized, secure computing that mimics biology's efficiency, positioning it for commercialization around 2025.[1][3][6]
Catalog Technologies was founded in 2016 in Boston by MIT scientists, including co-founder and CEO Hyunjun Park, who drew inspiration from DNA's natural role as a low-energy, high-density data storage and computation medium used by biology for billions of years.[1][3] The idea emerged to solve pain points in conventional storage like flash drives and hard drives, which consume excessive energy, face space limits, and pose security risks amid surging data growth.[3][6]
Early traction came from proprietary innovations like a revolutionary data-encoding scheme minimizing costly DNA synthesis, enabling commercial viability beyond academic proofs-of-concept.[3] Pivotal moments include developing the Shannon DNA writer prototype using inkjet-like technology, raising $35M in Series B funding to scale computation features, and partnerships such as with Seagate for storage platforms.[3][4][5]
Catalog stands out in DNA data tech through these key strengths:
Catalog rides the AI-driven data explosion trend, where conventional computing can't sustain 175 zettabytes of global data by 2025 without massive energy and infrastructure costs.[4][6] Timing is critical as AI workloads demand parallel, low-power solutions; DNA computing's biological parallelism disrupts data centers' stadium-scale growth.[1][5]
Market forces like rising energy prices and sustainability mandates favor Catalog, bridging academic DNA storage concepts to real-world apps in finance, manufacturing, and energy.[3] It influences the ecosystem by pioneering scalable DNA platforms, partnering with storage giants like Seagate, and proving viability through prototypes like Shannon, potentially slashing marginal data insight costs.[4][5]
Catalog is poised to commercialize its full DNA computing platform by 2025, expanding from storage to advanced computation for AI-era workloads.[1][3] Trends like hyperscale data growth and green computing will accelerate adoption, with influence evolving from niche innovator to infrastructure staple via deeper enterprise integrations and cost reductions.[6]
As DNA unlocks negligible-cost insights from archives without mega-data centers, Catalog could redefine the data economy—echoing its origins in biology's timeless efficiency.[1][6]
Catalog has raised $65.8M in total across 8 funding rounds.
Catalog's investors include 50 Partners, eFounders, Elaia Partners, Factorial, Motier Ventures, Singular, The Hit Forge, Alexandre Scialom, Charles Gorintin, Florian Douetteau, Rand Hindi, Thibaud Elziere.
Catalog has raised $65.8M across 8 funding rounds. Most recently, it raised $3.0M Seed in March 2024.